Outlook Therapeutics Inc
NASDAQ:OTLK
Outlook Therapeutics Inc
Total Other Income
Outlook Therapeutics Inc
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Outlook Therapeutics Inc
NASDAQ:OTLK
|
Total Other Income
-$97m
|
CAGR 3-Years
-546%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
-$3.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-62%
|
CAGR 10-Years
-78%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$158m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$151m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
-$55.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
-$31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Outlook Therapeutics Inc's Total Other Income?
Total Other Income
-97m
USD
Based on the financial report for Mar 31, 2024, Outlook Therapeutics Inc's Total Other Income amounts to -97m USD.
What is Outlook Therapeutics Inc's Total Other Income growth rate?
Total Other Income CAGR 3Y
-546%
Over the last year, the Total Other Income growth was -107 708%. The average annual Total Other Income growth rates for Outlook Therapeutics Inc have been -546% over the past three years .